Welcome to LookChem.com Sign In|Join Free

CAS

  • or

289-95-2

Post Buying Request

289-95-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

289-95-2 Usage

Uses

Different sources of media describe the Uses of 289-95-2 differently. You can refer to the following data:
1. Pyrimidine is a heterocyclic organic molecule present in many pharmaceutical and naturally derived compounds. Used in the synthesis and discovery of antiviral medication, such as in the case of HIV and HSV. Also used in the synthesis of potent inhibitors of 15-lipoxygenase in the reduction of the release of leukotrienes.
2. 1. It has no direct applications itself with its derivatives cytosine, uracil and thymine being important components of nucleic acid. Many drugs (such as sulfadiazine, trimethoprim and 6-mercaptopurine) contain pyrimidine ring. 2. Pyrimidine is widely used as pharmaceutical raw materials for the production of vitamin B, sulfadiazine, sulfadimidine, sulfamonomethoxine pyrimidine; pesticide raw materials, such as diazinon, pyrimidinol, blasticidin, bromacil, rumacil, crimidine, dodemorph, dimethirimol, ethirimol, bupirimate, pirazinon, pirimicarb, primicid, pirimiphos-methyl, polyoxin, pyramat, Pirimiphos-ethyl, etrimfos, triarimol, fenarimol and uracil, etc.; dye raw materials, for example, dyes with trihalogenated pyrimidine nucleus can react well with fiber and as reactive dyes, they have attracted people's attention. 3. It can be used as pharmaceutical intermediates, raw materials such as photosensitive agent
3. Pyrimidine is used as building block in chemical synthesis. Product Data Sheet
4. Pyrimidine was used to assess the extent of pyrimidine/purine asymmetry quantitatively. It was also used to study the photoinduced ion chemistry of the halogenated pyrimidines, a class of prototype radiosensitizing molecules.

Six-membered heterocyclic compounds

Pyridine, also known as "metadiazine", is a six-membered heteroaromatic ring compound containing two nitrogen atoms in the meta-position, being isomers with pyridazine and pyrazine. It has a molecular formula of C4H4N2 with the molecular weight being 80.09. It appears as colorless liquid or solid crystals with a pungent odor. It has a melting temperature of 20~22 ℃, boiling point of 123~124 °C and refractive index of 1.4998 (20 °C). It is easily soluble in water, ethanol and ether with weak alkaline and being capable of forming salts with acid. Its alkalinity is weaker than pyridine. It is also more difficult for it to participate into electrophilic substitution reaction than pyridine. It can only undergo bromination at the 5th position and is not capable of having nitrification and sulfonation reaction, but more prone to participate into nucleophilic substitution. Pyrimidine derivatives are widely found in nature. For example, vitamin B1, uracil, cytosine and thymine all contain pyrimidine structure. Its picrate salt appears as yellow needle-like crystals. It has a melting temperature of 156 °C. Owing to the presence of conjugated double bonds in the structure, pyrimidine has strong absorption capability on ultraviolet light. It is manufactured through phosphorus oxychloride oxidation of barbituric acid, followed by reduction through hydrogen iodide. Nucleic acid contains three important pyrimidine derivatives, being an important base in nucleic acid, plays an important role in the body of organisms. DNA mainly contains cytosine and thymine while RNA mainly contains cytosine and uracil, in some nucleic acids, there are also small amount of pyrimidine modified base, for example: Sulfadiazine and its derivatives are commonly used antibacterial anti-inflammatory drugs. The above information is edited by Andy Edwards of lookchem.

Pyrimidine base

Pyrimidine base is one of the chemical compositions of the nucleotides. It consists of carbon, nitrogen, hydrogen, oxygen and other elements. Pyrimidine bases include uracil, cytosine, and thymine, where uracil and cytosine constitute the bases in ribonucleic acid molecules while thymine and cytosine constitute bases in deoxyribonucleic acid molecules. Pyrimidine base has a strong absorption on ultraviolet in the wavelength of 250~280nm. The raw materials for its synthesis are derived from carbamoyl phosphate and aspartic acid. Pyrimidine base can also be metabolized into carbon dioxide, β-alanine and β amino-isobutyric acid and other substances. Some patients, due to congenital factors or taking certain drugs, can get pyrimidine alkali metabolic disorders, causing whey aciduria.

The functions of purine, pyrimidine and other substances

Purines and pyrimidines are essential heterocyclic nitrogen-containing compounds that used in nucleic acid metabolism in organisms (including humans) and are important substances in the formation of ribonucleic acid and deoxyribonucleic acid in cells. Purine, pyrimidine and ribose and phosphate can combine to form RNA; purine, pyrimidine and deoxyribose can bind to phosphate to produce DNA. DNA is the main chemical constituent of genes, which plays an important role in the transmission of genes (genetics); the main function of RNA is the regulation of intracellular protein synthesis. The final product of purine metabolism is mainly uric acid. Barley and malt contains 0.2% to 0.3% of the dry matter of nucleic acid. Upon the saccharification, the dry matter of nucleic acid can be subject to the degradation of various phosphatases to form nucleotides, nucleosides, purines and pyrimidine and many other degradation products, of which only purine and pyrimidine can enter into yeast cells to constitute ribonucleic acid, deoxyribonucleic acid, adenosine triphosphate and some coenzymes. Nucleotides are difficult to be absorbed. If the medium is lack of purine and pyrimidine, the cells have to rely on carbohydrates and amino acids for synthesis, thus consuming a lot of energy and influence the proliferation of yeast. In general, wort is not lack of the required purine and pyrimidine. References: Chinese Medical Encyclopedia Editorial Board Editor; Guo Di editor in chief. Chinese Encyclopedia of Medicine ? fifty-seven pediatrics.

Preparation

1, take malondialdehyde and formamide as raw materials and have reaction upon heating; we can obtain pyrimidine. 2, it can be manufactured through the catalytic hydrogenation of 2, 4-dichloropyrimidine in the system. 3, use zinc powder to reduce 2, 4, 6-trichloropyrimidine, pyrimidine can be obtained. 4, the reaction between ethyl acetoacetate and amidine (below) can produce pyrimidine.

Fluorouracil

Fluorouracil is a pyrimidine antimetabolite. In the body, it is first converted into 5-fluoro-2-deoxyuridine nucleotides (FUdRP), causing inhibition of thymidylate synthase (TMPS), preventing the conversion of deoxyuridine nucleotide into thymidine, interfering with DNA synthesis and leading to cell damage and death. It has a stronger effect in the presence of leucovorin (CF) because FUdRP, FH4 and TMPS can form triple complexes making the active metabolite of drug bind more tightly with the enzyme, so addition of CF when applying will yield better efficacy, especially improving the efficacy upon being applied to colorectal cancer. This product is cell cycle-specific drugs with killing effects on proliferated cells at all stages. It is most sensitive to the S phase, and also has retardation effect on the G1/S border. Oral absorption is not complete, and the drug is easily inactivated upon liver metabolism. After intravenous infusion or arterial infusion, the blood concentration is relatively stable. Fluorouracil has relative significant effect against choriocarcinoma and malignant mole. It also has certain curative effects on gastric cancer, colon cancer, rectum cancer, liver cancer, pancreatic cancer, breast cancer, ovarian cancer, cervical cancer, prostate cancer, bladder cancer, kidney cancer, lung cancer, head and neck cancer and skin cancer.

Chemical properties

It appears as colorless crystalline or liquid.

Chemical Properties

Colourless to pale yellow liquid

Definition

Different sources of media describe the Definition of 289-95-2 differently. You can refer to the following data:
1. One of a group of basic compounds found in living matter. They may be isolated fol- lowing complete hydrolysis of nucleic acids. They include uracil, thymine, cytosine, and methylcy- tosine. Thiamine is also a pyrimidine derivative. Other pyrimidines such
2. A simple nitrogenous organic molecule whose ring structure is contained in the pyrimidine bases cytosine, thymine, and uracil, which are constituents of the nucleic acids.
3. pyrimidine: An organic nitrogenousbase (see formula), sparinglysoluble in water, that gives rise to agroup of biologically important derivatives,notably uracil, thymine,and cytosine, which occur in nucleotidesand nucleic acids (DNA andRNA).

Check Digit Verification of cas no

The CAS Registry Mumber 289-95-2 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 2,8 and 9 respectively; the second part has 2 digits, 9 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 289-95:
(5*2)+(4*8)+(3*9)+(2*9)+(1*5)=92
92 % 10 = 2
So 289-95-2 is a valid CAS Registry Number.
InChI:InChI=1/C4H4N2/c1-2-5-4-6-3-1/h1-4H

289-95-2 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (A15534)  Pyrimidine, 99%   

  • 289-95-2

  • 1g

  • 344.0CNY

  • Detail
  • Alfa Aesar

  • (A15534)  Pyrimidine, 99%   

  • 289-95-2

  • 5g

  • 1104.0CNY

  • Detail
  • Alfa Aesar

  • (A15534)  Pyrimidine, 99%   

  • 289-95-2

  • 25g

  • 4461.0CNY

  • Detail
  • Aldrich

  • (131695)  Pyrimidine  ≥98.0%

  • 289-95-2

  • 131695-1G

  • 428.22CNY

  • Detail
  • Aldrich

  • (131695)  Pyrimidine  ≥98.0%

  • 289-95-2

  • 131695-5G

  • 1,359.54CNY

  • Detail
  • Aldrich

  • (131695)  Pyrimidine  ≥98.0%

  • 289-95-2

  • 131695-25G

  • 5,782.14CNY

  • Detail

289-95-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name pyrimidine

1.2 Other means of identification

Product number -
Other names iazine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:289-95-2 SDS

289-95-2Synthetic route

2-thioxopyrimidine
1450-85-7

2-thioxopyrimidine

PYRIMIDINE
289-95-2

PYRIMIDINE

Conditions
ConditionsYield
With dihydrogen peroxide; acetic acid at 25℃; for 0.0833333h;85%
With ozone In acetic acid at 25℃; for 0.5h;64%
With ozone In acetic acid at 25℃; for 0.5h;64%
5-bromopyrimidine
4595-59-9

5-bromopyrimidine

A

PYRIMIDINE
289-95-2

PYRIMIDINE

B

5-methoxypyrimidine
31458-33-0

5-methoxypyrimidine

Conditions
ConditionsYield
With sodium methylate In methanol; ethyl acetateA n/a
B 70%
pyrimidin-5-amine
591-55-9

pyrimidin-5-amine

PYRIMIDINE
289-95-2

PYRIMIDINE

Conditions
ConditionsYield
With isopentyl nitrite In tetrahydrofuran at 120℃; under 5250.53 Torr; for 0.333333h;55%
5-bromopyrimidine
4595-59-9

5-bromopyrimidine

PYRIMIDINE
289-95-2

PYRIMIDINE

Conditions
ConditionsYield
With triethylamine In methanol; water at 4℃; for 24h; Irradiation; sensitizer: methylene blue;52%
With methyl phenylphosphinate; tetrabutylammomium bromide; tetra-(n-butyl)ammonium iodide; ethylene dibromide; triethylamine In N,N-dimethyl-formamide; acetonitrile at 20℃; Electrochemical reaction;
2,4-Diphenyl-1-pyrimidin-2-yl-5,6-dihydro-benzo[h]quinolinium; fluoride
81454-19-5

2,4-Diphenyl-1-pyrimidin-2-yl-5,6-dihydro-benzo[h]quinolinium; fluoride

A

PYRIMIDINE
289-95-2

PYRIMIDINE

B

2,4-diphenylbenzo[h]quinoline
34987-58-1

2,4-diphenylbenzo[h]quinoline

Conditions
ConditionsYield
With 2,4,6-triphenylpyridine at 250℃; for 6h;A 51%
B n/a
pyrimidine N-oxide
17043-94-6

pyrimidine N-oxide

tert-butyl-isopropyl-thioketene
54439-99-5

tert-butyl-isopropyl-thioketene

A

PYRIMIDINE
289-95-2

PYRIMIDINE

B

3-tert-butyl-3-isopropylthiirane-2-one
63702-81-8

3-tert-butyl-3-isopropylthiirane-2-one

Conditions
ConditionsYield
In chloroform-d1 for 168h; Ambient temperature; study of sulfur transfer reaction;A 50%
B 44%
1-mercaptopyrimidine

1-mercaptopyrimidine

Chloromethyl pivalate
18997-19-8

Chloromethyl pivalate

A

PYRIMIDINE
289-95-2

PYRIMIDINE

B

2-Pivalyloxymethylthiopyrimidine
80693-26-1

2-Pivalyloxymethylthiopyrimidine

Conditions
ConditionsYield
With triethylamine In dichloromethaneA 49%
B n/a
2-Benzyl-pyrimidine 1-oxide
90210-54-1

2-Benzyl-pyrimidine 1-oxide

A

PYRIMIDINE
289-95-2

PYRIMIDINE

B

2-methylpyrimidine
5053-43-0

2-methylpyrimidine

C

benzyl-pyrimidine
90210-57-4

benzyl-pyrimidine

D

pyrimido[1,2-a]indole
245-46-5

pyrimido[1,2-a]indole

Conditions
ConditionsYield
at 800℃; under 0.0001 - 0.0006 Torr;A 2%
B n/a
C 17%
D 48%
4-Benzyl-pyrimidine 3-oxide
90210-55-2

4-Benzyl-pyrimidine 3-oxide

A

PYRIMIDINE
289-95-2

PYRIMIDINE

B

4-Methylpyrimidine
3438-46-8

4-Methylpyrimidine

C

4-benzylpyrimidine
64660-82-8

4-benzylpyrimidine

D

pyrimido-[1,6-a]indole
23989-28-8

pyrimido-[1,6-a]indole

Conditions
ConditionsYield
at 800℃; under 0.0001 - 0.0006 Torr;A 14%
B n/a
C 13%
D 45%
2,6-Dichloropyrimidine
3934-20-1

2,6-Dichloropyrimidine

PYRIMIDINE
289-95-2

PYRIMIDINE

Conditions
ConditionsYield
With sodium hydroxide; palladium on activated charcoal; diethyl ether Hydrogenation;
With palladium on activated charcoal; ethanol; magnesium oxide Hydrogenation;
2,5-dichloropyrimidine
22536-67-0

2,5-dichloropyrimidine

PYRIMIDINE
289-95-2

PYRIMIDINE

Conditions
ConditionsYield
With Pd-BaSO4; water; magnesium oxide Hydrogenation;
4,6-dichloropyrimidine
1193-21-1

4,6-dichloropyrimidine

PYRIMIDINE
289-95-2

PYRIMIDINE

Conditions
ConditionsYield
With sodium hydroxide; palladium on activated charcoal; diethyl ether Hydrogenation;
pyrimidine-4-carboxylic acid
31462-59-6

pyrimidine-4-carboxylic acid

PYRIMIDINE
289-95-2

PYRIMIDINE

Conditions
ConditionsYield
ueber den Schmelzpunkt;
2,4,6-trichloropyrimidine
3764-01-0

2,4,6-trichloropyrimidine

PYRIMIDINE
289-95-2

PYRIMIDINE

Conditions
ConditionsYield
With water; zinc
With sodium hydroxide; palladium on activated charcoal; diethyl ether Hydrogenation;
pyrimidine-4,6-dicarboxylic acid
16490-02-1

pyrimidine-4,6-dicarboxylic acid

PYRIMIDINE
289-95-2

PYRIMIDINE

Conditions
ConditionsYield
With diphenylether at 240℃;
pyrimidine-4,6-dicarboxylic acid
16490-02-1

pyrimidine-4,6-dicarboxylic acid

A

PYRIMIDINE
289-95-2

PYRIMIDINE

B

methylammonium carbonate
15719-64-9, 15719-76-3, 97762-63-5

methylammonium carbonate

2,4,5,6-tetrachloropyrimidine
1780-40-1

2,4,5,6-tetrachloropyrimidine

PYRIMIDINE
289-95-2

PYRIMIDINE

Conditions
ConditionsYield
With water; zinc
With sodium hydroxide; palladium on activated charcoal; diethyl ether Hydrogenation;
3-(N-Methylanilino)-2-propenal
14189-82-3

3-(N-Methylanilino)-2-propenal

PYRIMIDINE
289-95-2

PYRIMIDINE

Conditions
ConditionsYield
With ethanol; nitrogen at 200℃; Leiten ueber einen Montmorillonit-Katalysator;
malondialdehyde bis(diethyl acetal)
122-31-6

malondialdehyde bis(diethyl acetal)

PYRIMIDINE
289-95-2

PYRIMIDINE

Conditions
ConditionsYield
With ethanol; nitrogen at 200℃; Leiten ueber einen Montmorillonit-Katalysator;
malonaldehydebis(dimethylacetal)
102-52-3

malonaldehydebis(dimethylacetal)

PYRIMIDINE
289-95-2

PYRIMIDINE

Conditions
ConditionsYield
With ethanol; nitrogen at 200℃; Leiten ueber einen Montmorillonit-Katalysator;
Propiolaldehyde diethyl acetal
10160-87-9

Propiolaldehyde diethyl acetal

PYRIMIDINE
289-95-2

PYRIMIDINE

Conditions
ConditionsYield
With ethanol; water; ammonium formate
1,1,3-triethoxy-3-methoxy-propane
5468-58-6

1,1,3-triethoxy-3-methoxy-propane

PYRIMIDINE
289-95-2

PYRIMIDINE

Conditions
ConditionsYield
With ethanol; nitrogen at 200℃; Leiten ueber einen Montmorillonit-Katalysator;
With water; ammonium formate at 190℃;
3-(N,N-diethylamino)propenal
13070-22-9

3-(N,N-diethylamino)propenal

PYRIMIDINE
289-95-2

PYRIMIDINE

methyl N-acetylglycinate
1117-77-7

methyl N-acetylglycinate

pyrimidine cation
17009-95-9

pyrimidine cation

A

PYRIMIDINE
289-95-2

PYRIMIDINE

B

C5H10NO3(1+)
88001-14-3

C5H10NO3(1+)

Conditions
ConditionsYield
In cyclohexane Thermodynamic data; ΔH and ΔS (proton transfer);
nopinone
24903-95-5

nopinone

1-dimethylamino-3-dimethylimonioprop-1-ene perchlorate

1-dimethylamino-3-dimethylimonioprop-1-ene perchlorate

A

pyridine
110-86-1

pyridine

B

PYRIMIDINE
289-95-2

PYRIMIDINE

C

10,10-Dimethyl-3-aza-tricyclo[7.1.1.02,7]undeca-2(7),3,5-triene
117648-73-4

10,10-Dimethyl-3-aza-tricyclo[7.1.1.02,7]undeca-2(7),3,5-triene

Conditions
ConditionsYield
Multistep reaction. Yields of byproduct given;
Yield given. Multistep reaction;
N-Benzylpyrimidinium bromide
82619-53-2

N-Benzylpyrimidinium bromide

PYRIMIDINE
289-95-2

PYRIMIDINE

Conditions
ConditionsYield
With ammonia Product distribution; Mechanism; Ambient temperature;
PYRIMIDINE
289-95-2

PYRIMIDINE

[CuCl(PPh3)2(4-methylpyridine)]

[CuCl(PPh3)2(4-methylpyridine)]

[CuCl(PPh3)2(pyrimidine)]

[CuCl(PPh3)2(pyrimidine)]

Conditions
ConditionsYield
In neat (no solvent, gas phase)100%
In diethyl ether18%
PYRIMIDINE
289-95-2

PYRIMIDINE

C72(13)C2H132Cl8P4Pt2Ru2

C72(13)C2H132Cl8P4Pt2Ru2

C76(13)C2H136Cl8N2P4Pt2Ru2

C76(13)C2H136Cl8N2P4Pt2Ru2

Conditions
ConditionsYield
In dichloromethane100%
PYRIMIDINE
289-95-2

PYRIMIDINE

C48H44B2N2

C48H44B2N2

C46H32B2N2

C46H32B2N2

Conditions
ConditionsYield
In benzene-d6 Inert atmosphere;100%
PYRIMIDINE
289-95-2

PYRIMIDINE

4,4,5,5-tetramethyl-[1,3,2]-dioxaboralane
25015-63-8

4,4,5,5-tetramethyl-[1,3,2]-dioxaboralane

1,3-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,2,3,4-tetrahydropyrimidine

1,3-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,2,3,4-tetrahydropyrimidine

Conditions
ConditionsYield
With C22H27N3 In benzene-d6 at 70℃; for 12h; Glovebox;99%
With C22H27N3 In benzene-d6 at 20℃; for 12h; Schlenk technique;98%
With C14H22N2P(1+)*CF3O3S(1-) In [D3]acetonitrile at 28℃; for 1h; Inert atmosphere; Glovebox; Sealed tube; regioselective reaction;91%
PYRIMIDINE
289-95-2

PYRIMIDINE

methyl iodide
74-88-4

methyl iodide

1-methylpyrimidin-1-ium iodide
60544-22-1

1-methylpyrimidin-1-ium iodide

Conditions
ConditionsYield
at 25℃; for 3h;98%
In neat (no solvent) at 20℃; for 3h; Inert atmosphere;93%
In neat (no solvent) for 18h; Schlenk technique; Inert atmosphere; Darkness;61%
With methanol
PYRIMIDINE
289-95-2

PYRIMIDINE

triphenylphosphine
603-35-0

triphenylphosphine

copper(I) bromide
7787-70-4

copper(I) bromide

[(CuBr(P(C6H5)3))2(pyrimidine)]

[(CuBr(P(C6H5)3))2(pyrimidine)]

Conditions
ConditionsYield
In chloroform; acetonitrile copper salt and phosphine (1:1) dissolved in CHCl3 at 25°C, slight excess ligand in CH3CN added, pptd on stirring; filtered off, washed (Et2O), dried (vac.), elem. anal.;98%
In acetonitrile addn. of ligand to a soln. of copper salt and phosphine in acetonitrile,standing for 2 wk; elem. anal.;25%
PYRIMIDINE
289-95-2

PYRIMIDINE

2-fluoroethyl bromide
762-49-2

2-fluoroethyl bromide

1-(1-fluoroethyl)pyrimidinum bromide

1-(1-fluoroethyl)pyrimidinum bromide

Conditions
ConditionsYield
at 80℃; for 48h;97%
PYRIMIDINE
289-95-2

PYRIMIDINE

1-iodo-propane
107-08-4

1-iodo-propane

1-propylpyrimidinium iodide

1-propylpyrimidinium iodide

Conditions
ConditionsYield
at 75℃; for 24h;97%
PYRIMIDINE
289-95-2

PYRIMIDINE

1-Bromo-3-fluoropropane
352-91-0

1-Bromo-3-fluoropropane

1-(1-fluoropropyl)pyrimidinium bromide

1-(1-fluoropropyl)pyrimidinium bromide

Conditions
ConditionsYield
at 110℃;96%
potassium hexafluorophosphate
17084-13-8

potassium hexafluorophosphate

PYRIMIDINE
289-95-2

PYRIMIDINE

cis-dichloro(2,2′-bipyridine)ruthenium(II)chloride

cis-dichloro(2,2′-bipyridine)ruthenium(II)chloride

cis-[Ru(2,2'-bipyridyl)2(pyrimidine)2]2+

cis-[Ru(2,2'-bipyridyl)2(pyrimidine)2]2+

Conditions
ConditionsYield
Stage #1: PYRIMIDINE; cis-dichloro(2,2′-bipyridine)ruthenium(II)chloride In ethanol; water for 12h; Reflux;
Stage #2: potassium hexafluorophosphate In water
96%
PYRIMIDINE
289-95-2

PYRIMIDINE

1,1,1-trifluoro-3-iodopropane
460-37-7

1,1,1-trifluoro-3-iodopropane

1-(3,3,3-trifluoropropyl)pyrimidinium iodide

1-(3,3,3-trifluoropropyl)pyrimidinium iodide

Conditions
ConditionsYield
95%
PYRIMIDINE
289-95-2

PYRIMIDINE

potassium tetrachloroaurate(III) dihydrate

potassium tetrachloroaurate(III) dihydrate

[AuCl3(1,3-diazine)]
1233385-52-8

[AuCl3(1,3-diazine)]

Conditions
ConditionsYield
In methanol; water dropwise addn. of soln. of N compd. in methanol to aq. soln. of Au compd.; filtration, washing with water, drying under vacuum;95%
PYRIMIDINE
289-95-2

PYRIMIDINE

[platinum(II)(iodide)(cyclopropylamine)(μ-iodide)platinum(II)(cyclopropylamine)(iodide)]
105691-69-8, 868061-38-5

[platinum(II)(iodide)(cyclopropylamine)(μ-iodide)platinum(II)(cyclopropylamine)(iodide)]

[platinum(II)(cyclopropylamine)(pyrimidine)diiodide]
1229343-12-7, 1229597-93-6, 1229598-01-9

[platinum(II)(cyclopropylamine)(pyrimidine)diiodide]

Conditions
ConditionsYield
In H2O small excess of N2C4H4 (0.42 mmol) (in H2O) slowly added to suspn. of Ptcomplex (0.2 mmol), stirred at room temp. in the dark during 9 d; 80% cis and 20% trans isomers mixt.;95%
PYRIMIDINE
289-95-2

PYRIMIDINE

(trinitromethyl)borane-THF complex

(trinitromethyl)borane-THF complex

C5H6BN5O6

C5H6BN5O6

Conditions
ConditionsYield
In benzene at 15 - 20℃; for 2h;95%
PYRIMIDINE
289-95-2

PYRIMIDINE

allyltributylstanane
24850-33-7

allyltributylstanane

2,2,2-Trichloroethyl chloroformate
17341-93-4

2,2,2-Trichloroethyl chloroformate

2,4-diallyl-1,3-bis(2,2,2-trichloroethoxycarbonyl)-1,2,3,4-tetrahydropyrimidine

2,4-diallyl-1,3-bis(2,2,2-trichloroethoxycarbonyl)-1,2,3,4-tetrahydropyrimidine

Conditions
ConditionsYield
In dichloromethane at 0℃; for 2h;94%
PYRIMIDINE
289-95-2

PYRIMIDINE

methanol
67-56-1

methanol

2,4-dimethoxy-1,3-dinitro-1,2,3,4-tetrahydropyrimidine

2,4-dimethoxy-1,3-dinitro-1,2,3,4-tetrahydropyrimidine

Conditions
ConditionsYield
With dinitrogen pentoxide In nitromethane at 0℃; for 0.5h;94%
PYRIMIDINE
289-95-2

PYRIMIDINE

nickel(II) nitrate hexahydrate

nickel(II) nitrate hexahydrate

[Ni(μ-pyrimidine)(H2O)2(NO3)2](n)

[Ni(μ-pyrimidine)(H2O)2(NO3)2](n)

Conditions
ConditionsYield
In dichloromethane; isopropyl alcohol metal nitrate in iPrOH added to soln. of ligand in CH2Cl2; filtered, dried (vac.), elem. anal.;94%
PYRIMIDINE
289-95-2

PYRIMIDINE

zinc dibromide

zinc dibromide

bis(dibromido)bis(pyrimidine-N)(μ2-pyrimidine-N,N')dizinc(II)
1121760-22-2

bis(dibromido)bis(pyrimidine-N)(μ2-pyrimidine-N,N')dizinc(II)

Conditions
ConditionsYield
In acetonitrile ZnBr2 (0.5 mmol) and pyrimidine (1.0 mmol) mixed in CH3CN; Et2O added; elem. anal.;93.77%
PYRIMIDINE
289-95-2

PYRIMIDINE

phenylboronic acid
98-80-6

phenylboronic acid

4-phenylpyrimidine
3438-48-0

4-phenylpyrimidine

Conditions
ConditionsYield
With iron sulfide; dipotassium peroxodisulfate; trifluoroacetic acid In dichloromethane; water at 20℃; for 40h; regioselective reaction;93.4%
With dipotassium peroxodisulfate In water; acetone at 160℃; for 0.75h; Sealed tube;37%
PYRIMIDINE
289-95-2

PYRIMIDINE

potassium trichloro(dimethylsulfoxide)platinate(II)
31168-86-2

potassium trichloro(dimethylsulfoxide)platinate(II)

trans-[Pt(dimethylsulfoxide)Cl2]2(μ-pyrimidine)
370570-91-5

trans-[Pt(dimethylsulfoxide)Cl2]2(μ-pyrimidine)

Conditions
ConditionsYield
In water byproducts: KCl; Pt complex and pyrimidine dissolved in water in a 2:1 molar ratio at room temp.; a yellow ppt. formed immediately; stirred at room temp. until the soln. became colorless; ppt. filtered off, dried, washed with ether and dried in vacuo; X-ray detn.;93%
PYRIMIDINE
289-95-2

PYRIMIDINE

water
7732-18-5

water

copper diacetate
142-71-2

copper diacetate

sodium ethyl tetrazolate-5-carboxylate

sodium ethyl tetrazolate-5-carboxylate

[Cu(tetrazolate-5-carboxylate)(pyrimidine)(H2O)]n

[Cu(tetrazolate-5-carboxylate)(pyrimidine)(H2O)]n

Conditions
ConditionsYield
In water High Pressure; Cu(CH3COO)2 (0.2 mmol), (CN4)COOEtNa (0.2 mmol) and pyrimidine (0.2 mmol) in H2O heated in closed vial (100°C, 1 d); decanted; washed with H2O; filtered off; washed with EtOH and Et2O; dried in air; PXRD; elem. anal.;93%
PYRIMIDINE
289-95-2

PYRIMIDINE

1,8-bis[(diphenylboranyl)ethynyl]anthracene

1,8-bis[(diphenylboranyl)ethynyl]anthracene

C46H32B2N2

C46H32B2N2

Conditions
ConditionsYield
In dichloromethane at 20℃; Solvent; Inert atmosphere;93%
PYRIMIDINE
289-95-2

PYRIMIDINE

pyrimidine N-oxide
17043-94-6

pyrimidine N-oxide

Conditions
ConditionsYield
With 3-chloro-benzenecarboperoxoic acid In dichloromethane for 16h;92%
With 3-chloro-benzenecarboperoxoic acid In dichloromethane at 24℃; for 12h; Inert atmosphere;74%
With phosphomolybdic acid; dihydrogen peroxide In water; acetonitrile at 50℃; for 12h;61%
PYRIMIDINE
289-95-2

PYRIMIDINE

ethyl iodide
75-03-6

ethyl iodide

1-ethylpyrimidin-1-ium iodide

1-ethylpyrimidin-1-ium iodide

Conditions
ConditionsYield
In neat (no solvent) at 65 - 80℃; Inert atmosphere;92%
at 25℃; Rate constant; various solvents; effect of substituent and solvents on the reactivity;
PYRIMIDINE
289-95-2

PYRIMIDINE

cobalt pivalate

cobalt pivalate

water
7732-18-5

water

acetonitrile
75-05-8

acetonitrile

bis(μ-pyrimidine)bis(μ-pivalate)bis(μ-aqua)bis(pivalate)dicobalt(II)-acetonitrile (1/1)

bis(μ-pyrimidine)bis(μ-pivalate)bis(μ-aqua)bis(pivalate)dicobalt(II)-acetonitrile (1/1)

Conditions
ConditionsYield
In acetonitrile refluxed for 1 h; filtered, concd., cooled to room temp., crysts. dried (air stream); elem. anal.;92%
PYRIMIDINE
289-95-2

PYRIMIDINE

propyl bromide
106-94-5

propyl bromide

1-propylpyrimidin-1-ium bromide

1-propylpyrimidin-1-ium bromide

Conditions
ConditionsYield
In neat (no solvent) at 65 - 80℃; Inert atmosphere;92%
PYRIMIDINE
289-95-2

PYRIMIDINE

heptanal
111-71-7

heptanal

4-heptanoylpyrimidine

4-heptanoylpyrimidine

Conditions
ConditionsYield
With N-hydroxyphthalimide; cobalt(III) acetylacetonate; cobalt acetylacetonate In benzonitrile; trifluoroacetic acid at 70℃; for 12h;91%
PYRIMIDINE
289-95-2

PYRIMIDINE

[(Nb6Cl12)Cl2(H2O)4]*4H2O

[(Nb6Cl12)Cl2(H2O)4]*4H2O

dichloromethane
75-09-2

dichloromethane

[Nb6Cl14(pyrimidine)4]·2.5CH2Cl2

[Nb6Cl14(pyrimidine)4]·2.5CH2Cl2

Conditions
ConditionsYield
With acetic anhydride at 40℃; for 96h;91%
PYRIMIDINE
289-95-2

PYRIMIDINE

phenyl chloroformate
1885-14-9

phenyl chloroformate

diphenyl pyrimidine-1,3(2H,4H)-dicarboxylate

diphenyl pyrimidine-1,3(2H,4H)-dicarboxylate

Conditions
ConditionsYield
Stage #1: PYRIMIDINE; phenyl chloroformate With trimethylamine-borane In acetonitrile for 0.0833333h; Cooling;
Stage #2: With trimethylamine-borane In acetonitrile at 20℃; for 0.166667h; Cooling; regioselective reaction;
91%
PYRIMIDINE
289-95-2

PYRIMIDINE

bis(2,2'-bipyridine)ruthenium(II)-nitrosyl-chloride hexafluorophosphate

bis(2,2'-bipyridine)ruthenium(II)-nitrosyl-chloride hexafluorophosphate

{((2,2'-bipyridine)2Ru(II)Cl)2(pyrimidine)}(PF6)2*H2O

{((2,2'-bipyridine)2Ru(II)Cl)2(pyrimidine)}(PF6)2*H2O

Conditions
ConditionsYield
With potassium azide In methanol; acetone byproducts: KPF6; light protection; solns. KN3 and Ru-salt mixed dropwise, stirred for 15 min, ligand added, refluxed (Ar, 20 h); volume reduced (vac.), acetone added, volume reduced, soln. filtered, pptd. (dry ethyl ether), filtered off, dried (vac.), washed (water), dried (vac.), repptd. (acetone/ether); elem. anal.;90%

289-95-2Relevant articles and documents

Nickel-Catalyzed Electrosynthesis of Aryl and Vinyl Phosphinates

Daili, Farah,Ouarti, Abdelhakim,Pinaud, Marine,Kribii, Ibtihal,Sengmany, Stéphane,Le Gall, Erwan,Léonel, Eric

supporting information, p. 3452 - 3455 (2020/05/25)

A mild and useful nickel-catalyzed electrochemical phosphonylation of aryl and vinyl bromides is described. We show that alkyl H-phenylphosphinates can be coupled electrochemically with functionalized aryl and vinyl bromides using very simple conditions (Fe/Ni anode, bench-stable nickel pre-catalyst, undivided cell, galvanostatic electrolysis) to furnish the corresponding aryl and vinyl phosphinates in satisfactory to good yields. Couplings can also be applied to heteroaromatic bromides with some limitations like increased propensity to hydro-dehalogenation.

Flow hydrodediazoniation of aromatic heterocycles

R?der, Liesa,Nicholls, Alexander J.,Baxendale, Ian R.

, (2019/06/05)

Continuous flow processing was applied for the rapid replacement of an aromatic amino group with a hydride. The approach was applied to a range of aromatic heterocycles, confirming the wide scope and substituent-tolerance of the processes. Flow equipment was utilized and the process optimised to overcome the problematically-unstable intermediates that have restricted yields in previous studies relying on batch procedures. Various common organic solvents were investigated as potential hydride sources. The approach has allowed key structures, such as amino-pyrazoles and aminopyridines, to be deaminated in good yield using a purely organic-soluble system.

Infrared spectra of pyrazine, pyrimidine and pyridazine in solid argon

Breda,Reva,Lapinski,Nowak,Fausto

, p. 193 - 206 (2007/10/03)

The vibrational spectra of monomeric diazines (pyrazine, pyrimidine and pyridazine) isolated in solid argon and of the neat crystalline phase of these compounds, at 10 K, are reported and discussed. Full assignment of the spectra is presented, providing evidence that the assignments of several bands previously undertaken for the compounds under other experimental conditions (e.g., gas phase, neat liquid or solution) shall be reconsidered. The interpretation of the experimental data is supported by extensive DFT calculations performed with the B3LYP functional and the 6-311++G(d,p) basis set and by comparison with the anharmonic vibrational calculations reported by Boese and Martin [J.Phys.Chem. A, 108 (2004) 3085] and Berezin et al. [Russian J.Phys.Chem., 79 (2005) 425; Opt.Spectrosc., 97 (2004) 201]. Spectra/structure correlations were extracted from the data, enabling to conclude that, while the π-electron systems in both pyrazine and pyrimidine rings are strongly delocalized over all heavy-atoms, in pyridazine the canonical form with one CC and two CN double bonds strongly predominates. Finally, the UV-induced photoisomerization of matrix isolated monomeric pyrazine to pyrimidine is reported.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 289-95-2